SCHEMBL1098749

SCHEMBL1098749

CC(C)(c1cccc(C(C)(C)c2ccc(C(=O)O)c(C(=O)O)c2)c1)c1ccc(C(=O)O)c(C(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.53
ESR2 Q92731 2/20 0.53
TDP1 Q9NUW8 1/20 0.50
RXRB P28702 4/20 0.42
ALDH1A1 P00352 4/20 0.42
CYP3A4 P08684 1/20 0.42
SORT1 Q99523 3/20 0.42
HSD17B10 Q99714 2/20 0.42
CDC25A P30304 1/20 0.42
CDC25B P30305 1/20 0.42
ALOX15 P16050 2/20 0.41
NOTUM Q6P988 1/20 0.41
RXRA P19793 3/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
GRIK1 P39086 1/20 0.39
KDM4C Q9H3R0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29396119 1.00 ESR1 (0.53) ESR1ESR2TDP1RXRBALDH1A1
SCHEMBL8579977 0.93 ALDH1A1 (0.52) ESR1ESR2TDP1RXRBALDH1A1
SCHEMBL29441322 0.92 TDP1 (0.56) ESR1ESR2TDP1RXRBALDH1A1
SCHEMBL29361914 0.92 TDP1 (0.56) ESR1ESR2TDP1RXRBALDH1A1
SCHEMBL105948 0.92 TDP1 (0.56) ESR1ESR2TDP1RXRBALDH1A1
SCHEMBL267196 0.90 TDP1 (0.54) ESR1ESR2TDP1RXRBALDH1A1
SCHEMBL1098811 0.90 TDP1 (0.54) ESR1ESR2TDP1RXRBALDH1A1
SCHEMBL29393207 0.90 TDP1 (0.54) ESR1ESR2TDP1RXRBALDH1A1
SCHEMBL10483760 0.90 TDP1 (0.53) ESR1ESR2TDP1RXRBHSD17B10
SCHEMBL10464421 0.86 ESR1 (0.55) ESR1ESR2TDP1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112346273-A Flexible liquid crystal display device 旭化成株式会社 2021-02-09 CN claimed
WO-2026100585-A1 CURABLE RESIN COMPOSITION, PREPREG, AND CURED PRODUCTS THEREOF 日本化薬株式会社 2026-05-15 WO disclosed
US-20260117059-A1 CURABLE RESIN, CURABLE RESIN COMPOSITION, CURED PRODUCT, PREPREG, LAMINATE, AND SEMICONDUCTOR SUBSTRATE NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2026-04-30 US disclosed
US-20260109854-A1 CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2026-04-23 US disclosed
US-20260109853-A1 CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2026-04-23 US disclosed
US-20260109801-A1 MALEIMIDE RESIN MIXTURE, CURABLE RESIN COMPOSITION, VARNISH, AND CURED PRODUCT THEREOF NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2026-04-23 US disclosed
US-12595334-B2 Compound, mixture, curable resin composition and cured product thereof, and method for producing compound NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2026-04-07 US disclosed
US-20260078208-A1 COMPOUND, CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2026-03-19 US disclosed
EP-4641693-A1 POLYIMIDE COMPOUND, NEGATIVE ELECTRODE MATERIAL FOR LITHIUM ION SECONDARY BATTERIES THAT USES SAID POLYIMIDE COMPOUND, NEGATIVE ELECTRODE FOR LITHIUM ION SECONDARY BATTERIES, AND LITHIUM ION SECONDARY BATTERY Wingo Technology Co., Ltd. (JP) 2025-10-29 EP disclosed
US-12410281-B2 Diamine compound, polyimide precursor and polyimide film using the same, and use thereof SK INNOVATION CO., LTD. (KR) 2025-09-09 US disclosed
WO-2007092011-A1 PHOTOSENSITIVE POLYIMIDE COMPOSITION AND POLYIMIDE PRECURSOR COMPOSITION CENTRAL GLASS CO., LTD. (JP) 2007-08-16 WO disclosed
US-6933411-B2 Aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2005-08-23 US disclosed
US-6737503-B2 LOW TEMPERATURE ADHESIVE BONDING MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20040082754-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2004-04-29 US disclosed
US-20030092870-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2003-05-15 US disclosed
EP-1288191-A2 Novel aromatic diamine and polyimide thereof Mitsui Chemicals, Inc. (JP) 2003-03-05 EP disclosed
US-6183934-B1 FOE USE IN FORMATION OF PATTERN OF INSULATION FILM, PASSIVATION FILM, .ALPHA.-RAY SHIELDING FILM, OPTICAL WAVEGUIDE KABUSHIKI KAISHA TOSHIBA (JP) 2001-02-06 US disclosed
US-6159654-A Negative photosensitive polymer composition of a thermosetting polymer precursor curable by cyclodehydration upon heating KABUSHIKI KAISHA TOSHIBA (JP) 2000-12-12 US disclosed
US-6001517-A A THERMOSETTING POLYMER WHICH CAN BE CURED THROUGH CYCLODEHYDRATION UPON HEATING AND A CURE ACCELERATOR WHICH CAN BE DEACTIVATED OF ITS CURE ACCELERATION PROPERTY BY IRRIDIATION OF LIGHT KABUSHIKI KAISHA TOSHIBA (JP) 1999-12-14 US disclosed
US-5578697-A DIELECTRIC POLYMERS FOR ELECTRONICS KABUSHIKI KAISHA TOSHIBA (JP) 1996-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260109854-A1 CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF MLLT1, CRBN, POT1 ESR1 385/4885ESR2 482/4885TDP1 1635/4885
US-20030092870-A1 Novel aromatic diamine and polyimide thereof DDT, AOC1, H1-4 ESR1 3429/4885ESR2 4308/4885TDP1 799/4885
US-20260109801-A1 MALEIMIDE RESIN MIXTURE, CURABLE RESIN COMPOSITION, VARNISH, AND CURED PRODUCT THEREOF SMC4, MECP2, SMC3 ESR1 2150/4885ESR2 2008/4885TDP1 2571/4885
US-20260117059-A1 CURABLE RESIN, CURABLE RESIN COMPOSITION, CURED PRODUCT, PREPREG, LAMINATE, AND SEMICONDUCTOR SUBSTRATE RAD51, ASH2L, H1-0 ESR1 227/4885ESR2 875/4885TDP1 1049/4885
US-20260078208-A1 COMPOUND, CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME BMI1, SEM1, PSMB2 ESR1 823/4885ESR2 236/4885TDP1 2886/4885
US-12410281-B2 Diamine compound, polyimide precursor and polyimide film using the same, and use thereof PUF60, PARG, DDT ESR1 4655/4885ESR2 4739/4885TDP1 817/4885
US-20260109853-A1 CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME PSMA1, PSMB10, RAD51 ESR1 168/4885ESR2 219/4885TDP1 1275/4885
US-12595334-B2 Compound, mixture, curable resin composition and cured product thereof, and method for producing compound RER1, RXRA, TERB1 ESR1 579/4885ESR2 467/4885TDP1 2310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.